All terms in EFO
| Label | Id | Description |
|---|---|---|
| prothrombin fragments F1+2 measurement | EFO_0007776 | [quantification of the amount of prothrombin fragments F1+2 in a sample] |
| thrombin-antithrombin complex measurement | EFO_0007775 | [quantification of the amount of thrombin-antithrombin complex in a sample] |
| head circumference | EFO_0005114 | [A circumferential measurement of the head at the widest point, which is traditionally above the eyebrow] |
| thrombomodulin measurement | EFO_0007774 | [quantification of the amount of thrombomodulin in a sample] |
| folic acid | CHEBI_27470 | |
| cutaneous psoriasis measurement | EFO_0007773 | [quantification of the presence or absence of psoriatic arthritis in patients with psoriasis vulgaris] |
| serum paraoxonase/arylesterase 1 measurement | EFO_0020736 | [The determination of the amount of serum paraoxonase/arylesterase 1 in a sample] |
| CCL5 measurement | EFO_0005117 | [Is the quantification of Chemokine (C-C motif) ligand 5. CCL5 is a Chemoattractant for blood monocytes, memory T-helper cells and eosinophils. Causes the release of histamine from basophils and activates eosinophils. May activate several chemokine receptors including CCR1, CCR3, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant RANTES protein induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form RANTES(3-68) acts as a natural chemotaxis inhibitor and is a more potent inhibitor of HIV-1-infection. The second processed form RANTES(4-68) exhibits reduced chemotactic and HIV-suppressive activity compared with RANTES(1-68) and RANTES(3-68) and is generated by an unidentified enzyme associated with monocytes and neutrophils (PubMed:16791620, PubMed:1380064, PubMed:8525373, PubMed:9516414, PubMed:15923218). May also be an agonist of the G protein-coupled receptor GPR75, stimulating inositol trisphosphate production and calcium mobilization through its activation. Together with GPR75, may play a role in neuron survival through activation of a downstream signaling pathway involving the PI3, Akt and MAP kinases. By activating GPR75 may also play a role in insulin secretion by islet cells (PubMed:23979485). ] |
| sh2 domain-containing protein 1a measurement | EFO_0020737 | [The determination of the amount of sh2 domain-containing protein 1a in a sample] |
| response to pazopanib | EFO_0007779 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus with pazopanib, a multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis, used to treat renal cell carcinoma and soft tissue sarcoma] |
| IGFBP-1 measurement | EFO_0005118 | [IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. Promotes cell migration.] |
| m-hydroxyhippurate | CHEBI_133607 | [A monocarboxylic acid anion that is the conjugate base of m-hydroxyhippuric acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.] |
| shc-transforming protein 1 measurement | EFO_0020738 | [The determination of the amount of shc-transforming protein 1 in a sample] |
| urinary albumin to creatinine ratio | EFO_0007778 | [quantification of the ratio of albumin to creatinine in a urine sample] |
| Arachnodactyly - abnormal ossification - intellectual disability | Orphanet_1129 | |
| sialic acid-binding ig-like lectin 7 measurement | EFO_0020739 | [The determination of the amount of sialic acid-binding ig-like lectin 7 in a sample] |
| base metabolic rate measurement | EFO_0007777 | [quantification of an individual's base metabolic rate, the minimum amount of energy required to sustain life while at complete rest, including the body being in a post-absorptive state (ie the digestive system is inactive). BMR differs from RMR because BMR measurements must meet total physiological equilibrium whereas RMR conditions of measurement can be altered and defined by the contextual limitations.] |
| obsolete_aprosencephaly cerebellar dysgenesis | Orphanet_1126 | |
| serine/threonine-protein kinase PLK1 measurement | EFO_0020732 | [The determination of the amount of serine/threonine-protein kinase PLK1 in a sample] |
| serine/threonine-protein kinase receptor R3 measurement | EFO_0020733 | [The determination of the amount of serine/threonine-protein kinase receptor R3 in a sample] |